West Nile virus has been isolated for the first time in Mexico, from a sick person and from mosquitoes (Culex quinquefasciatus). Partial sequencing and analysis of the 2 isolates indicate that they are genetically similar to other recent isolates from northern Mexico and the western United States.
S everal recent reports (1-7) have documented the widespread geographic distribution of West Nile virus (WNV) in Mexico, but until now, no autochthonous human cases of illness due to this virus have been reported from the republic. Likewise, limited entomologic surveillance has been conducted in Mexico, and no information is available on the actual mosquito vectors of WNV in the republic. All Mexican WNV isolates studied to date have come from dead equines or birds (2, 7, 8) . We report the first isolations of WNV from a sick person and from a pool of Culex quinquefasciatus mosquitoes and describe their phylogenetic relationship to other representative WNV strains from the United States and Mexico.
The Study
Mosquitoes were collected from June to September 2003 at the Ejido Francisco Villa, Municipality of Pesqueria, State of Nuevo Leon (25°47′N, 100°03′W), with CDC-type light traps baited with dry ice and mechanical aspiration from resting sites on vegetation and in houses. The area is located ≈40 km northeast of Monterrey and consists of mixed suburban housing and agriculture. Average annual rainfall in the region is 550 mm; the mean annual temperature is 28°C. After collection, the mosquitoes were placed on dry ice for transport back to the Medical Entomology Laboratory, Faculty of Biological Sciences, Autonomous University of Nuevo Leon, Monterrey, where they were separated into pools of ≈10 insects each, based on species, date, and method of collection ( Table 1 ). The mosquitoes were stored in a mechanical freezer at -70°C and later transported on dry ice to the University of Texas Medical Branch (UTMB) to be processed for virus isolation. A total of 2,297 mosquitoes, representing 4 genera and 11 species, were tested in 238 pools (Table 1) . Individual mosquito pools were titrated manually in sterile, Ten Broeck tissue grinders containing 1.0 mL of phosphate-buffered saline, pH 7.4, containing 30% fetal bovine serum and antimicrobial agents (penicillin, streptomycin, and amphotericin). The resultant suspension was centrifuged at 12,000 rpm for 5 min; then 200 µL of the supernatant was injected into a flask culture of Vero cells. After the solution was absorbed for 1 h at 37°C, maintenance medium (9) was added; cultures were maintained in an incubator at 37°C and examined daily for evidence of viral cytopathic effect (CPE) for 14 days.
A single pool of Cx. quinquefasciatus yielded a virus isolate, designated NL-54, which produced CPE on approximately day 7. The isolate was identified as WNV by immunofluorescence, hemagglutination-inhibition (HI) test, complement-fixation test, VecTest WNV/SLE antigen assay (Medical Analysis Systems, Camarillo, CA, USA), and reverse transcription-polymerase chain reaction (RT-PCR) (9, 10) .
The WNV human isolate was from a 62-year-old Mexican woman living in the municipality of Etchojoa (near Ciudad Obregon) in Sonora State. The patient had no history of travel during the preceding 2 months. She visited a local hospital in July 2004 with symptoms of fever, headache, vomiting, arthralgias, and myalgia. Her temperature was 38°C upon examination, and no neurologic symptoms were noted. An acute-phase blood sample was obtained, and a presumptive diagnosis of dengue fever was made. The patient was sent home and subsequently completely recovered. When RT-PCR using dengue primers was negative on the acute-phase serum, a culture was performed. WNV was isolated from the sample at the State Public Health Laboratory in Sonora and at UTMB, upon culture in Vero cells. HI tests conducted on the acute-phase serum at UTMB with West Nile, St. Louis encephalitis, yellow fever, dengue 1, and dengue 2 viral antigens were negative, which indicated that the patient had no preexisting flavivirus antibodies. An immunoglobulin (Ig) M enzyme-linked immunosorbent assay (11) , performed on the acute-phase specimen and a 30-day convalescentphase serum specimen in Sonora, demonstrated seroconversion and the presence of WNV-reactive IgM antibodies in the convalescent-phase serum sample.
Viral RNA was extracted from the 2 WNV strains after a single Vero cell passage directly from 140 µL of the infected cell culture supernatants, using the QIAamp viral RNA extraction kit (12) . RT-PCR was performed by using 3 primer pairs to amplify the entire prM-E genes of each WNV isolate as previously described (12) . PCR products were gel purified with the QIAquick kit (Qiagen, Valencia, CA, USA) according to the manufacturer's protocol, and the resulting template was directly sequenced with the amplifying primers. Sequencing reactions were performed as described previously (8) . Analysis and assembly of sequencing data were performed with the Vector NTI Suite software package (Informax, Frederick, MD, USA). Nucleotide and deduced amino acid sequences of the 2004-nucleotide region representing the prM-E genes from each isolate were aligned with the AlignX program in the Vector NTI Suite and compared to sequences of selected North American WNV isolates for which the prM-E genes were available in GenBank. Phylogenetic trees were constructed by Bayesian analysis with the program MRBAYES, version 2.0 (13), with the Metropolis-coupled, Markov chain, Monte Carlo algorithm run with 4 chains over 150,000 generations under a general time-reversible model with a burn-in time of 50,000 generations. Rate heterogeneity was estimated by using a γ distribution for the variable sites. The Bayesian consensus tree was compared to trees generated by neighbor-joining, maximum parsimony, and maximum likelihood analyses using PAUP, version 4.0b10 (14) , and each method generated trees with the same overall topology. The consensus phylogram of the 40 WNV isolates generated by Bayesian analysis (13) is shown in the Figure, with confidence values at relevant nodes to demonstrate statistical support for each clade.
Conclusions
Comparison of the 2 Mexican isolates, NL-54 (GenBank accession no. AY963775) and human Sonora (GenBank accession no. AY963774), to the prototypical North American WNV isolate, WN-NY99 (GenBank accession no. AF196835), 2 previous Mexican isolates, MexNL-03 (GenBank accession no. AY426741) (7) and TM171-03 (GenBank accession no. AY371271) (2) , and an isolate collected in Harris County, Texas, in 2002 (GenBank accession no. AY185906) (15) indicated nucleotide and deduced amino acid differences and similarities among each of the isolates. Table 2 shows the positions at which nucleotide and amino acid substitutions were found. Both the Mexican mosquito and human isolates reported herein shared a nucleotide mutation at position 660 (C to U) of the prM gene and 2 mutations at positions 1442 (U to C) and 2466 (C to U) of the E gene. Each of these 3 mutations was shared with a 2003 horse strain from Nuevo Leon (MexNL-03) (7) Our patient represents the first reported autochthonous human case of confirmed WNV infection in Mexico. The paucity of human cases reported to date from Mexico is curious for several reasons: 1) a large number of cases are reported from the United States, 2) available evidence indicates that WNV is now widely distributed in Mexico (1-7), 3) most of the WNV virus strains circulating in the republic are genetically similar to those in the United States (Figure) . One explanation for this difference could be the failure of local health personnel to recognize the various clinical forms of WNV infection. As illustrated by our patient, West Nile fever can easily be mistaken for dengue fever. A second reason may be the difficulty of making a serologic diagnosis of WNV infection among persons living in geographic regions where several different flaviviruses circulate, and people have multiple flavivirus infections (11) . A third and related possibility is that WNV infection may be less severe in persons with preexisting heterologous flavivirus antibodies (11) .
